Provigil Sleep Apnea Studies To Finish in 2000, Will Be First sNDA Filed - CEO

Clinical data from Cephalon's Provigil trials in sleep apnea patients will be available in early 2000, with a supplemental NDA filing to be discussed after that, Cephalon CEO Frank Baldino, PhD, said Jan. 13 at the Hambrecht & Quist conference in San Francisco.